Visgeneer Asset Resilience Ratio

Latest as of June 2021: 1.34%

Visgeneer asset resilience ratio. Visgeneer (4197) has an Asset Resilience Ratio of 1.34% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4197 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

NT$5.80 Million

≈ $182.73K USD Cash + Short-term Investments

Total Assets

NT$433.46 Million

≈ $13.66 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Visgeneer (2013–2021)

Asset resilience ratio of Visgeneer from 2013 to 2021. This chart shows how Visgeneer's Asset Resilience Ratio has changed over time. Read Visgeneer balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Visgeneer's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 4197 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$5.80 Million	1.34%
Total Liquid Assets	NT$5.80 Million	1.34%

Asset Resilience Insights

Limited Liquidity: Visgeneer maintains only 1.34% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Visgeneer Industry Peers by Asset Resilience Ratio

Compare Visgeneer's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Visgeneer Asset Resilience Ratio by Year (2013–2021)

Visgeneer asset resilience ratio by year from 2013 to 2021. The table below shows the annual Asset Resilience Ratio data for Visgeneer.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	1.36%	NT$5.80 Million ≈ $182.73K	NT$427.04 Million ≈ $13.45 Million	-8.53pp
2020-12-31	9.89%	NT$45.67 Million ≈ $1.44 Million	NT$461.96 Million ≈ $14.55 Million	+8.68pp
2019-12-31	1.21%	NT$5.80 Million ≈ $182.73K	NT$480.76 Million ≈ $15.15 Million	-0.08pp
2018-12-31	1.29%	NT$5.80 Million ≈ $182.73K	NT$451.24 Million ≈ $14.22 Million	-0.79pp
2013-12-31	2.08%	NT$6.90 Million ≈ $217.39K	NT$332.39 Million ≈ $10.47 Million	--

pp = percentage points

About Visgeneer

TWO:4197 Taiwan Biotechnology

Market Cap

$7.54 Million

NT$239.34 Million TWD

Market Cap Rank

#27604 Global

#1586 in Taiwan

Share Price

NT$7.93

Change (1 day)

-3.29%

52-Week Range

NT$7.93 - NT$19.00

All Time High

NT$28.80